Status:
COMPLETED
Continuous Positive Airway Pressure on Acute Stroke and Obstructive Sleep Apnea
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Stroke, Acute
Obstructive Sleep Apnea
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Stroke affects 16.9 million individuals each year and is the second leading cause of death worldwide. Despite advances in pharmacologic therapy, morbidity , mortality and rates of hospitalization for ...
Eligibility Criteria
Inclusion
- Time from onset of stroke symptoms to hospital arrival \<2 weeks .
- Stroke is documented with brain magnetic imaging or computed tomography
- Competency to provide informed consent.
- Moderate to severe obstructive sleep apnea being established with the use of a home sleep-study screening device (ApneaLink).
- Epworth sleepiness scale≦10.
Exclusion
- Having received CPAP for obstructive sleep apnea prior to admission.
- History of pneumothorax or brain surgery.
- Coexisting heart failure or renal failure or persistent atrial fibrillation.
- Unable to wear a nasal or nasal-oral mask.
- Concomitant uncontrolled infection.
- Swallowing difficulty or episodes of choking due to stroke
- Coexisting central nervous diseases such as dementia
Key Trial Info
Start Date :
July 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04458779
Start Date
July 9 2020
End Date
December 31 2024
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan